Search
for

    Research 10 of 1000+

    1. Three-Month Treatment With a Long-Acting Gonadotropin-Releasing Hormone Agonist of Patients With Benign Prostatic Hyperplasia: Effects on Tissue Androgen Concentration, 5<i>α</i>-Reductase Activity and Androgen Receptor Content* 1989 · 82 citations
    2. Androgen-induced norepinephrine release in male accessory sex organ smooth muscle growth and differentiation 2019
    3. Age‐dependent regulation by androgens of gene expression in the anterior hypothalamus and stress‐induced release of adrenal hormones in adolescent and adult male rats Journal of neuroendocrinology · 2019 · 10 citations
    4. Pharmacokinetics of 2 Novel Formulations of Modified-Release Oral Testosterone Alone and With Finasteride in Normal Men With Experimental Hypogonadism International Journal of Andrology · 2010 · 6 citations
    5. Long-Term Suppression of Testosterone After Treatment with a Gonadotropin-Releasing Hormone Agonist in a Woman with a Presumed Testosterone Secreting Ovarian Tumor The Journal of Clinical Endocrinology & Metabolism · 1997 · 19 citations
    6. Effect of the gonadotrophin releasing hormone analogue, goserelin, and oestradiol replacement on sebum excretion rates and hair size in mildly hirsute women Journal of dermatological treatment · 1991 · 4 citations
    7. Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women Endocrinology, Diabetes & Metabolism Case Reports · 2018 · 4 citations
    8. Clinical Utility of GnRH Analogues in Female Androgen Excess: Highlighting Diagnostic and Therapeutic Applications JCEM case reports · 2023 · 1 citations
    9. DIAGNOSTIC AND THERAPEUTIC UTILITY OF GONADOTROPHIN-RELEASING HORMONE AGONIST IN POSTMENOPAUSAL HYPERANDROGENISM OF OVARIAN ORIGIN Journal of the ASEAN Federation of Endocrine Societies · 2023
    10. Recent discoveries and developments of androgen receptor based therapy for prostate cancer MedChemComm · 2015 · 17 citations
    All research results →

    Community 10 of 345

    1. Breezula phase 3 results said to be released next month Reddit · 28 Dec 2024
    2. Pyrilutamide phase III clinical trial results released Reddit · 27 Nov 2023
    3. Any idea when clascoterone will actually be released? Reddit · 19 Dec 2025
    4. Most Promising Future Hair Loss Treatments In 2026 Reddit · 13 Sept 2026
    5. Everyone is ignoring that plasma finasteride levels are 100x lower with topical compared to oral. Reddit · 20 Jul 2024
    6. Grey Market GT20029 and Frequency of Application Reddit · 2 May 2024
    7. bro where tf is GT20029, Q1 2024 is over already Reddit · 12 Apr 2024
    8. GT20029: How It Works for Hair Loss - Hair Loss “Cure” Reddit · 2 Feb 2026
    9. What hormones should I have tested at a minimum before starting a DHT blocker or anti-androgen? Reddit · 14 Nov 2023
    10. Anti androgen shed all over scalp Reddit · 5 Nov 2023
    All community results →

    Learn 3 of 12

    1. RU58841 Experimental topical anti-androgen sold as a research chemical
    2. Clascoterone Topical androgen-receptor blocker, approved as an acne cream
    3. Pyrilutamide Experimental topical anti-androgen, also known as KX-826
    All learn results →